Saxagliptin + metformin

Details

Files

Generic Name:

Saxagliptin + metformin

Project Status:

Withdrawn

Therapeutic Area:

Diabetes Mellitus, Type 2

Manufacturer:

Bristol-Myers Squibb / AstraZeneca Canada Inc.

Call for patient/clinician input open:

June 13, 2013

Brand Name:

Komboglyze

Project Line:

Reimbursement Review

Project Number:

SR0336-000

Call for patient/clinician input closed:

July 5, 2013

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Diabetes Mellitus, Type 2

Files

Submission Status Report View PDF

Last Updated : June 6, 2013